AI Bias Analysis
4 models · Takes ~15 seconds
CEO of BigHat Biosciences, which designs antibody therapies using machine-learning, on how AI can, and cannot, help in drug development.
Source
Stat News
Opens original article in a new tab
“Women and girls in eastern Congo will be harmed in predictable, named ways over the next 12 months,” write researchers Lindsay Stark and Ilana Seff.
WASHINGTON — People in the food world didn’t know what to expect when the Trump administration appointed a little-known Florida attorney as the FDA’s top food official in 2025. They…
A State Department plan scheduled to be implemented June 1 would strip the U.S. of decades of disease defense, write eight former CDC directors.
“Just because a company invests does not mean it has invented anything novel,” Tahir Amin and Rohit Malpani write in this excerpt from “Pharma Monopoly.”
